These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12836345)

  • 1. Application of schizophyllan as a novel gene carrier.
    Sakurai K; Kimura T; Koumoto K; Mizu M; Kobayashi R; Shinkai S
    Nucleic Acids Res Suppl; 2001; (1):223-4. PubMed ID: 12836345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel technique to specifically separate RNAs by Schizophyllan.
    Kimura T; Koumoto K; Mizu M; Kobayashi R; Sakurai K; Shinkai S
    Nucleic Acids Res Suppl; 2001; (1):283-4. PubMed ID: 12836375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of polynucleotides against nuclease-mediated hydrolysis by complexation with schizophyllan.
    Mizu M; Koumoto K; Kimura T; Sakurai K; Shinkai S
    Biomaterials; 2004 Jul; 25(15):3109-16. PubMed ID: 14967545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysaccharide--polynucleotide complexes. 2. Complementary polynucleotide mimic behavior of the natural polysaccharide schizophyllan in the macromolecular complex with single-stranded RNA and DNA.
    Sakurai K; Mizu M; Shinkai S
    Biomacromolecules; 2001; 2(3):641-50. PubMed ID: 11710016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEG-appended beta-(1-->3)-D-glucan schizophyllan to deliver antisense-oligonucleotides with avoiding lysosomal degradation.
    Karinaga R; Koumoto K; Mizu M; Anada T; Shinkai S; Sakurai K
    Biomaterials; 2005 Aug; 26(23):4866-73. PubMed ID: 15763266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligonucleotides bound in the polysaccharide complex and the enhanced antisense effect due to the low hydrolysis.
    Mizu M; Koumoto K; Anada T; Sakurai K; Shinkai S
    Biomaterials; 2004 Jul; 25(15):3117-23. PubMed ID: 14967546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemically modified polysaccharide schizophyllan for antisense oligonucleotides delivery to enhance the cellular uptake efficiency.
    Matsumoto T; Numata M; Anada T; Mizu M; Koumoto K; Sakurai K; Nagasaki T; Shinkai S
    Biochim Biophys Acta; 2004 Jan; 1670(2):91-104. PubMed ID: 14738991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ternary complex consisting of DNA, polycation, and a natural polysaccharide of schizophyllan to induce cellular uptake by antigen presenting cells.
    Takeda Y; Shimada N; Kaneko K; Shinkai S; Sakurai K
    Biomacromolecules; 2007 Apr; 8(4):1178-86. PubMed ID: 17328571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysaccharide/polynucleotide complexes. Part 6: complementary-strand-induced release of single-stranded DNA bound in the schizophyllan complex.
    Koumoto K; Mizu M; Sakurai K; Kunitake T; Shinkai S
    Chem Biodivers; 2004 Mar; 1(3):520-9. PubMed ID: 17191866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactose-appended schizophyllan is a potential candidate as a hepatocyte-targeted antisense carrier.
    Hasegawa T; Umeda M; Matsumoto T; Numata M; Mizu M; Koumoto K; Sakurai K; Shinkai S
    Chem Commun (Camb); 2004 Feb; (4):382-3. PubMed ID: 14765219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polysaccharide-polynucleotide complexes (15): thermal stability of schizophyllan (SPG)/poly(C) triple strands is controllable by alpha-amino acid modification.
    Numata M; Matsumoto T; Umeda M; Koumoto K; Sakurai K; Shinkai S
    Bioorg Chem; 2003 Apr; 31(2):163-71. PubMed ID: 12729573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of potent cell growth inhibition by schizophyllan/K-ras antisense complex in combination with gemcitabine.
    Sasaki S; Izumi H; Morimoto Y; Sakurai K; Mochizuki S
    Bioorg Med Chem; 2020 Sep; 28(18):115668. PubMed ID: 32828430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex consisting of antisense DNA and β-glucan promotes internalization into cell through Dectin-1 and hybridizes with target mRNA in cytosol.
    Fujiwara N; Izumi H; Morimoto Y; Sakurai K; Mochizuki S
    Cancer Gene Ther; 2019 Feb; 26(1-2):32-40. PubMed ID: 29970897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation technique for messenger RNAs by use of schizophyllan/poly(A) tail complexation.
    Kimura T; Beppu A; Sakurai K; Shinkai S
    Biomacromolecules; 2005; 6(1):174-9. PubMed ID: 15638518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysaccharide-polynucleotide complexes. Part 7. Hydrogen-ion and salt concentration dependence of complexation between schizophyllan and single-stranded homo RNAs.
    Sakurai K; Iguchi R; Mizu M; Koumoto K; Shinkai S
    Bioorg Chem; 2003 Jun; 31(3):216-26. PubMed ID: 12818231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal sequence of antisense DNA to silence YB-1 in lung cancer by use of a novel polysaccharide drug delivery system.
    Izumi H; Nagao S; Mochizuki S; Fujiwara N; Sakurai K; Morimoto Y
    Int J Oncol; 2016 Jun; 48(6):2472-8. PubMed ID: 27035516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysaccharide-polynucleotide complexes VIII. Cation-induced complex formation between polyuridylic acid and schizophyllan.
    Sakurai K; Iguchi R; Koumoto K; Kimura T; Mizu M; Hisaeda Y; Shinkai S
    Biopolymers; 2002 Oct; 65(1):1-9. PubMed ID: 12209467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new therapeutic approach using a schizophyllan-based drug delivery system for inflammatory bowel disease.
    Takedatsu H; Mitsuyama K; Mochizuki S; Kobayashi T; Sakurai K; Takeda H; Fujiyama Y; Koyama Y; Nishihira J; Sata M
    Mol Ther; 2012 Jun; 20(6):1234-41. PubMed ID: 22334022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro characterization of antigen-conjugated polysaccharide as a CpG DNA carrier.
    Shimada N; Ishii KJ; Takeda Y; Coban C; Torii Y; Shinkai S; Akira S; Sakurai K
    Bioconjug Chem; 2006; 17(5):1136-40. PubMed ID: 16984120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonucleotide delivery to antigen presenting cells by using schizophyllan.
    Mochizuki S; Miyamoto N; Sakurai K
    Drug Metab Pharmacokinet; 2022 Feb; 42():100434. PubMed ID: 34896749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.